Across Europe, cancer care is evolving - and JA PCM will help lead the way! 🌍 With 𝟭𝟰𝟱 𝐩𝐚𝐫𝐭𝐧𝐞𝐫𝐬 𝐮𝐧𝐢𝐭𝐞𝐝 𝐢𝐧 𝐨𝐧𝐞 𝐄𝐮𝐫𝐨𝐩𝐞𝐚𝐧 𝐉𝐨𝐢𝐧𝐭 𝐀𝐜𝐭𝐢𝐨𝐧, JA PCM is strengthening the PCM network across Europe. 🔎 Curious to learn more about our ambitious European Joint Action? Take a look: zenodo.org/records/1842...

🚀 We took part in the kick-off meeting of the @japcm.bsky.social: a new EU initiative to expand access to personalised cancer care across Europe. 🔬 As partners, VHIO lead a pilot to create a supranational Molecular Tumor Board for rare and complex cases and work on harmonising data collection.

We’re excited to kick off the Joint Action on Personalised Cancer Medicine (JA PCM) today in Brussels 🎉 Funded by #EU4Health, 146 organisations from 29 European countries are joining forces to advance personalised cancer care across the full patient pathway, from prevention to follow-up.